舌下神经刺激器植入在门诊手术中心与医院的比较
这项回顾性队列研究比较了122例舌下神经刺激器植入患者在门诊手术中心(ASC)与医院门诊部(HOPD)的安全性和效率。结果显示ASC组术后并发症无显著差异,但手术周转时间更短,且全国层面报销费用估计低18%。结论认为ASC植入安全、更高效且可能更具成本效益。
要点
- ASC组与HOPD组术后并发症无显著差异
- ASC组手术室内至切皮、关皮至出室及术后区域停留时间显著更短
- ASC组全国层面报销费用估计低18%
核心结论
- 舌下神经刺激器植入在ASC进行安全且比HOPD更高效,可能更具成本效益。
研究设计与样本
- 回顾性队列研究,纳入2015年5月至2021年1月在本院HOPD或ASC接受舌下神经刺激器植入的患者共122例。
主要发现
- ASC组从入室到手术开始、手术结束到出室、以及术后区域停留时间均显著短于HOPD组。
- 两组术后并发症无显著差异。
- 全国层面Medicare患者报销费用估计ASC比HOPD低18%。
临床怎么用
- 对于合适的OSA患者,可考虑在ASC进行舌下神经刺激器植入以缩短周转时间并可能降低费用。
局限性
- 回顾性研究设计,证据等级为3级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: Hypoglossal nerve stimulator (HGNS) implantation is highly effective in treating obstructive sleep apnea (OSA) in select patient populations that are intolerant of continuous positive airway pressure. Implantation surgery is traditionally performed in hospital outpatient departments (HOPD) due to concern about anesthetic effects and airway manipulation in an OSA population. In this study, we examined complications and efficiency of HGNS implantation in an ambulatory surgery center (ASC) versus HOPD. STUDY DESIGN: Retrospective cohort study. METHODS: Patients with HGNS implantation performed between May 2015-January 2021 at our HOPD or ACS were included. Patient-related characteristics, surgical times, and postoperative complications were obtained via chart review. Reimbursement data on a national level for Medicare patients were calculated based on publicly available data from the Center for Medicare Services. Patient characteristics, surgical times, and complications were summarized as medians with interquartile ranges (IQRs) and proportions in each surgical setting group as appropriate. These were compared between surgical setting groups via Wilcoxon rank-sum testing and χ2 testing. RESULTS: A total of 122 patients were included. Patients in the HOPD group had significantly higher median apnea-hypopnea index (AHI) (42.0 [IQR 27.9-51.0]) compared to the ASC group (31.0 [IQR 21.0-44.2], P = .005). The intervals between in-room and case start, case finish and out-of-room, and time in the postoperative area were significantly shorter in the ASC group compared to the HOPD group. Reimbursement on a national level was estimated at 18% lower for patients with surgery performed at the ASC. There was no significant difference in postoperative complications. CONCLUSIONS: HGNS implantation in an ASC is safe and more efficient than in a HOPD, and may also be more cost-effective. LEVEL OF EVIDENCE: 3 Laryngoscope, 132:706-710, 2022.
引用
- Morse E, Han C, Suurna M, et al. Hypoglossal Nerve Stimulator Implantation in an Ambulatory Surgery Center Versus Hospital. Laryngoscope. 2021. PMID: 34559404. doi:10.1002/lary.29875
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。